CIK 0001596967
- Large accelerated filer
Moelis & Co
Sign in to watch- Ticker
- MC
- Exchange
- NYSE
- Industry
- Investment Advice
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464500216
- Phone
- +1 212-883-3800
- Business address
- 399 PARK AVENUE, 5TH FLOOR, NEW YORK, NY, 10022
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $129,902
- in 1 filing
Net −$129,902. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-28 | Shropshire Kenneth Director | Grant or award | +26.48 | 2,531.65 | ||
| 2024-03-28 | Shropshire Kenneth Director | Grant or award | +1.57 | 150.08 | ||
| 2024-03-28 | Worrell Laila Director | Grant or award | +8.61 | 823.33 | ||
| 2024-03-28 | Worrell Laila Director | Grant or award | +3.75 | 359 | ||
| 2024-03-28 | Worrell Laila Director | Grant or award | +25.28 | 2,416.76 | ||
| 2024-03-28 | Worrell Laila Director | Grant or award | +6.93 | 662.41 | ||
| 2024-03-28 | Pilcher Ciafone Katherine Chief Operating Officer | Grant or award · 2019 Incentive RSUs | +28.07 | 2,684.16 | ||
| 2024-03-28 | Pilcher Ciafone Katherine Chief Operating Officer | Grant or award · 2020 Incentive RSUs | +28.92 | 2,765.62 | ||
| 2024-03-28 | Pilcher Ciafone Katherine Chief Operating Officer | Grant or award · 2021 Incentive RSUs | +41.21 | 3,939.9 | ||
| 2024-03-28 | Pilcher Ciafone Katherine Chief Operating Officer | Grant or award · 2022 Incentive RSUs | +78.15 | 7,472.93 | ||
| 2024-03-01 | MOELIS KENNETH Chairman, CEO | Sale | −4,000 | $54.08 | $216K | 82,441 |
| 2024-03-01 | MAHMOODZADEGAN NAVID Co-President, MD | Sale | −19,483 | $53.88 | $1.0M | 44,980 |
| 2024-02-29 | MOELIS KENNETH Chairman, CEO | Sale | −75,000 | $54.11 | $4.1M | 86,441 |
| 2024-02-29 | MAHMOODZADEGAN NAVID Co-President, MD | Sale | −50,772 | $54.11 | $2.7M | 64,463 |
| 2024-02-29 | SIMON JOSEPH Chief Financial Officer | Sale | −8,573 | $54.13 | $464K | 0 |
| 2024-02-29 | RAICH JEFFREY Co-President, MD | Sale | −44,710 | $54.23 | $2.4M | 0 |
| 2024-02-23 | RAICH JEFFREY Co-President, MD | Sale | −45,093 | $54.62 | $2.5M | 44,710 |
| 2024-02-23 | MOELIS KENNETH Chairman, CEO | Exercise or conversion | +31 | 161,841 | ||
| 2024-02-23 | MOELIS KENNETH Chairman, CEO | Sale | −400 | $55.00 | $22K | 161,441 |
| 2024-02-23 | MOELIS KENNETH Chairman, CEO | Exercise or conversion · Class B Common Stock, par value $0.01 | −57,490 | 4,432,288 |
Page 28 of 35 · 685 trades